Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 355-363

  Rivard, Alain ^a   Silver, Marcy ^a   Chen, Dongfen ^a   Kearney, Marianne ^a   Magner, Meredith ^a   Annex, Brian ^b   Peters, Kevin ^b   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; GENE THERAPY; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

EID: 0032965317     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65282-0     Document Type: Article

References (50)

1. Aronson D, Rayfield EJ: Diabetes and obesity. Atherosclerosis and Coronary Artery Disease. Edited by V Fuster, R Ross, EJ Topol. Philadelphia, Lippincott-Raven, 1996, pp 327-362
2. Barzilai JI, Kronmall RA, Bittner V, Eaker E, Evans C, Foster ED: Coronary artery disease and coronary artery bypass grafting in diabetic patients age ≥ 65 years (Report from Coronary Artery Surgery Study (CASS) Registry). Am J Cardiol 1994, 74:334
3. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979, 241:2035-2038
4. Currie CJ, Morgan CL, Peters JR: The epidemiology and cost of inpatient care of peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 1998, 21:42-48
5. Aronson D, Rayfield EJ: Diabetes. Textbook of Cardiovascular Medicine. Edited by EJ Topol. Philadelphia, Lippincott-Raven, 1998, pp 171-194
6. Towne JB: Management of loot lesions in the diabetic patient. Vascular Surgery. Edited by RB Rutherlord. Philadelphia. W. B. Saunders, 1989, p 895
7. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 1994, 93:662-670
8. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM: Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995, 147:1649-1660
9. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P: Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992, 16:181-191
10. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL: Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996, 79:62-69
11. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Linger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994, 89:2183-2189
12. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladston SR, Friedman M, Sellke FW, Simons M: Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995, 1:1085-1089
13. Lopez JJ, Edelman ER, Stamler A, Hibberd MG, Prasad P, Thomas KA, DiSalvo J, Caputo RP, Carrozza JP, Douglas PS, Sellke FW, Simons M: Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am J Physiol 1998, 274:H930-H936
14. Giordano FJ, Ping P, McKirnan D, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O, Hammond HK: Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996, 2:534-539
15. Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovosdi I, Itackett N, Isom OW, Crystal RG, Rosengart TK: Biologic bypass with the use of adenovirus-mediated gene transfer of the conplementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998, 115:168-176
16. Takeshita S, Tsurumi Y, Couffinhal T, Asahara T, Bauters C, Symes JF, Ferrara N, Isner JM: Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996, 75:487-502
17. 165. Lancet 1996, 348:370-374
18. Formby B, Miller N: Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single cell islet cells, an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Proc Natl Acad Sci USA 1990, 87:2438-2442
19. Fujishima Y, Koike Y, Kaidoh T, Nishimura M, Yoshida TO: Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its nondiabetic sister strains. Diabetologia 1989, 32:118-125
20. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM: A mouse model of angiogenesis. Am J Pathol 1998, 152:1667-1679
21. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998, 101:2567-2578
22. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes JF, Isner JM: Vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997, 150:1673-1685
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
24. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, while hypoxia upregulates VEGF express on only. Circulation 1994, 90:649-652
25. Tsurumi Y, Murohara T, Krasinski K, Dongfen C, Witzenbichler B, Kearney M, Couffinhal T, Isner JM: Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997, 3:879-886
26. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasguale LR, Theme H, Iwamoto MA, Parke JE, Nguyen MD, Aielle LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy anc other retinal disorders. N Engl J Med 1994, 331:1480-1487
27. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell SE: Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997, 124:433-446
28. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H: Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995, 27:48-52
29. Yarom R, Zirkin H, Stammler G, Rose AG: Human coronary microvessels in diabetes and ischaemia: morphometric study of autopsy material. J Pathol 1992, 166:265-270
30. D'Amore PA, Thompson RW: Mechanisms of angiogenesis. Annu Rev Physiol 1987, 49:453-464
31. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali J-R, Valensi P: Coronary artery responses to physiological stimuli are improved by Deferoxamine but not by -Arginire in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 1998, 97:736-743
32. Johnstone MD, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasocilation in patients with insulin-dependent diabetes melitus. Circulation 1993, 88:2510-2516
33. Lorenzi M, Nordberg JA, Toledo S: High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987, 36: 1261-1267
34. Salameh A, Zinn M, Dhein S: High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovasc Pharmacol 1997, 30:182-190
35. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 1992, 28A:787-790
36. Koch A, Harlow L, Haines G, Amento E, Unemori E, Wong W, Pope R, Ferrara N: Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994, 152: 4149-4156
37. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364
38. Stavn GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 1995, 92:11-14
39. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM: Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothehal growth factor, the case for paracrine amplification of angiogenesis. Circulation 1998, 97:381-390
40. Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB: Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 1996, 271:29483-29488
41. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes implications for normal and impaired wound healing. J Biol Chem 1995, 270:12607-12613
42. 165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998, 97:1114-1123
43. 165 as sole therapy for myocardial ischemia. Circulation 1998 (In press)
44. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM: Hypercholesterolemia attenuates angiogenesis but does not preculde augmentation by angiogenic cytokines. Circulation 1997, 962667-2674
45. Couffinhal T, Silver M, Kearney M, Sullivan A, Isner JM: Angiogenesis is impaired in ApoE knock out mice due to reduced expression of vascular endothelial growth factor. Circulation 1996, 94:1-102 (Abstract)
46. Rivard A, Fabre J-E, Silver M, Chen D, Murohara T, Kearney M, Magner M, Isner JM: Age-dependent impairment of angiogenesis. Circulation 1998 (In press)
47. Rensing BJ, Hermans WRM, Vos J, Tijssen JGP, Rutch W, Danchin N, Heyndrickx GP, Mast EG, Wijns W, Serruys PW, and on behalf of the Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group: Luminal narrowing after percutaneous transluminal coronary angioplasty: a study of clinical procedural and lesional factors related to long-term angiographic outcome Circulation 1993, 88:975-985
48. Alderman EL, Andrews K, Bost J, Bourassa M, Chaitma BR, Detre K, Faxon DP, Follman D, Frye RL, Hlaiky M, Jones RH, Kelsey SF, Rogers WJ, Rosen AD, Hartzell S, Sellers MA, Sopko G, Sutton-Tyrell K, Williams DO: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225
49. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995, 1:1024-1028
50. Peters KG, deVries C, Williams LT: Vascular endothehal growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993, 90:8915-8919